首页> 美国卫生研究院文献>Journal of Ophthalmic Vision Research >Combination Therapies in Ophthalmology: Implications for Intravitreal Delivery
【2h】

Combination Therapies in Ophthalmology: Implications for Intravitreal Delivery

机译:眼科联合疗法:玻璃体内给药的意义

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Most pathological processes involve complex molecular pathways that can only be modified or blocked by a combination of medications. Combination therapy has become a common practice in medicine. In ophthalmology, this approach has been used effectively to treat bacterial, fungal, proliferativeeoplastic, and inflammatory eye diseases and vascular proliferation. Combination therapy also encompasses the synergistic effect of electromagnetic radiation and medications. However, combination therapy can augment inherent complications of individual interventions, therefore vigilance is required. Complications of combination therapy include potential incompatibility among compounds and tissue toxicity. Understanding these effects will assist the ophthalmologist in his decision to maximize the benefits of combination therapy while avoiding an unfavorable outcome.
机译:大多数病理过程都涉及复杂的分子途径,这些途径只能通过药物联合来修饰或阻断。联合疗法已成为医学界的普遍做法。在眼科方面,这种方法已被有效地用于治疗细菌,真菌,增生/肿瘤,炎性眼病和血管增生。组合疗法还包括电磁辐射和药物的协同作用。但是,联合治疗可能会增加单个干预措施的固有并发症,因此需要保持警惕。联合疗法的并发症包括化合物之间潜在的不相容性和组织毒性。了解这些影响将有助于眼科医生做出最大的决定,即在避免不利结果的情况下综合治疗的益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号